Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.
Woodfield SE, Mistretta BJ, Patel RH, Ibarra AM, Fisher KE, Sarabia SF, Gandhi I, Reuther J, Starosolski Z, Badachhape A, Epps J, Zorman B, Shah AP, Larson SR, Srivastava RK, Shi Y, Espinoza AF, Govindu SR, Whitlock RS, Holloway K, Roy A, Sumazin P, Ghaghada KB, Lopez-Terrada D, Gunaratne PH, Vasudevan SA. Woodfield SE, et al. Among authors: sarabia sf. Biol Open. 2022 Sep 15;11(9):bio058973. doi: 10.1242/bio.058973. Epub 2022 Sep 12. Biol Open. 2022. PMID: 35451474 Free PMC article.
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Pozza A, Najaf Panah MJ, Epps JL, Scorsone K, Zorman B, Katzenstein H, O'Neill AF, Meyers R, Tiao G, Geller J, Ranganathan S, Rangaswami AA, Woodfield SE, Goss JA, Vasudevan SA, Heczey A, Roy A, Fisher KE, Alaggio R, Patel KR, Finegold MJ, López-Terrada DH. Sumazin P, et al. Among authors: sarabia sf. J Hepatol. 2022 Oct;77(4):1026-1037. doi: 10.1016/j.jhep.2022.04.035. Epub 2022 May 14. J Hepatol. 2022. PMID: 35577029 Free PMC article.
Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components.
Chen Wongworawat Y, Sarabia SF, Urbicain M, Francalanci P, Sumazin P, Alaggio R, López-Terrada DH. Chen Wongworawat Y, et al. Among authors: sarabia sf. Pediatr Dev Pathol. 2024 Mar-Apr;27(2):169-175. doi: 10.1177/10935266231204788. Epub 2023 Oct 30. Pediatr Dev Pathol. 2024. PMID: 37903123 Free PMC article.
Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
Espinoza AF, Patel KR, Shetty PB, Whitlock RS, Sumazin P, Yu X, Sarabia SF, Urbicain M, Heczey A, Masand P, Woodfield SE, López-Terrada DH, Vasudevan SA. Espinoza AF, et al. Among authors: sarabia sf. Cancer Med. 2023 Dec;12(23):21270-21278. doi: 10.1002/cam4.6705. Epub 2023 Nov 14. Cancer Med. 2023. PMID: 37962078 Free PMC article.
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma.
Espinoza AF, Patel RH, Patel KR, Badachhape AA, Whitlock R, Srivastava RK, Govindu SR, Duong A, Kona A, Kureti P, Armbruster B, Kats D, Srinivasan RR, Dobrolecki LE, Yu X, Najaf Panah MJ, Zorman B, Sarabia SF, Urbicain M, Major A, Bissig KD, Keller C, Lewis MT, Heczey A, Sumazin P, López-Terrada DH, Woodfield SE, Vasudevan SA. Espinoza AF, et al. Among authors: sarabia sf. J Hepatol. 2024 Apr;80(4):610-621. doi: 10.1016/j.jhep.2024.01.003. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242326
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Srivastava RK, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, López-Terrada D, Vasudevan SA. Woodfield SE, et al. Among authors: sarabia sf. Sci Rep. 2021 Feb 3;11(1):2967. doi: 10.1038/s41598-021-82542-4. Sci Rep. 2021. PMID: 33536467 Free PMC article.
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Srivastava RK, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, López-Terrada D, Vasudevan SA. Woodfield SE, et al. Among authors: sarabia sf. Sci Rep. 2021 Oct 1;11(1):19916. doi: 10.1038/s41598-021-98174-7. Sci Rep. 2021. PMID: 34599198 Free PMC article. No abstract available.
29 results